Alberto Amadori
Overview
Explore the profile of Alberto Amadori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
1974
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Amadori A, Real A, Brighi A, Russell S
J Adolesc
. 2025 Jan;
PMID: 39827373
Introduction: The impact of cyberbullying victimization on youth development, encompassing mental health, academic performance, and socioemotional well-being, has been widely documented. Research highlights the heightened vulnerability of sexual and gender...
2.
Brighi A, Amadori A, Summerer K, Menin D
Int J Clin Health Psychol
. 2023 Sep;
23(4):100414.
PMID: 37772270
Nonconsensual distribution of intimate images (NCII), also known as revenge porn, has become a significant social issue in recent years, with severe consequences for victims. The present study aimed to...
3.
Moserle L, Pons R, Martinez-Lozano M, Jimenez-Valerio G, Vidal A, Suarez C, et al.
EMBO Mol Med
. 2020 Nov;
12(12):e11889.
PMID: 33151035
An open debate in antiangiogenic therapies is about their consequence on tumor invasiveness and metastasis, which is undoubtedly relevant for patients currently treated with antiangiogenics, such as renal cell carcinoma...
4.
Boldrin E, Curtarello M, Fassan M, Rugge M, Realdon S, Alfieri R, et al.
Front Oncol
. 2020 Sep;
10:1320.
PMID: 32983964
Esophageal cancer (EC) is a highly aggressive tumor, and the current monitoring procedures are partially inadequate to evaluate treatment efficacy. The aim of this study was to investigate whether allelic...
5.
Bongiovanni D, Tosello V, Saccomani V, Santa S, Amadori A, Zanovello P, et al.
Oncogene
. 2020 Sep;
39(42):6544-6555.
PMID: 32917954
Notwithstanding intensified therapy, a considerable fraction of T-cell acute lymphoblastic leukemia (T-ALL) patients face a dismal prognosis due to primary resistance to treatment and relapse, raising the need for more...
6.
Tosello V, Bongiovanni D, Liu J, Pan Q, Yan K, Saccomani V, et al.
Leukemia
. 2020 Aug;
35(4):984-1000.
PMID: 32733009
T-cell acute lymphoblastic leukemia (T-ALL) is a highly malignant pediatric leukemia, where few therapeutic options are available for patients which relapse. We find that therapeutic targeting of GLI transcription factors...
7.
Zulato E, Attili I, Pavan A, Nardo G, Del Bianco P, Boscolo Bragadin A, et al.
Br J Cancer
. 2020 May;
123(1):81-91.
PMID: 32376889
Background: Liquid biopsy has the potential to monitor biological effects of treatment. KRAS represents the most commonly mutated oncogene in Caucasian non-small-cell lung cancer (NSCLC). The aim of this study...
8.
Rumiato E, Boldrin E, Malacrida S, Battaglia G, Sileni V, Ruol A, et al.
Pharmacogenomics
. 2020 Apr;
21(6):393-402.
PMID: 32285752
Clinical features of esophageal cancer (EC) patients have poor prognostic power. Thus, it is paramount to discover biomarkers that can allow a more accurate survival prediction. To detect genetic variants...
9.
Bellone M, Brevi A, Bruzzi S, Consonni M, De Santis F, Di Lullo G, et al.
Cancer Immunol Immunother
. 2020 Feb;
69(6):1141-1151.
PMID: 32025818
No abstract available.
10.
Mazzoldi E, Pasto A, Pilotto G, Minuzzo S, Piga I, Palumbo P, et al.
J Clin Med
. 2020 Feb;
9(2).
PMID: 32013179
The classical cancer stem cell (CSC) model places CSCs at the apex of a hierarchical scale, suggesting different genetic alterations in non-CSCs compared to CSCs, since an ill-defined number of...